Axxcess Wealth Management LLC purchased a new position in Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 6,561 shares of the company's stock, valued at approximately $221,000.
Other hedge funds also recently bought and sold shares of the company. Kovitz Investment Group Partners LLC purchased a new stake in Tempus AI during the 3rd quarter valued at $1,367,000. Victory Capital Management Inc. purchased a new stake in shares of Tempus AI during the fourth quarter valued at $216,000. China Universal Asset Management Co. Ltd. bought a new stake in Tempus AI in the 4th quarter worth about $1,091,000. Mirae Asset Global Investments Co. Ltd. purchased a new position in Tempus AI in the 4th quarter worth about $178,000. Finally, Captrust Financial Advisors bought a new position in Tempus AI during the 3rd quarter valued at about $2,726,000. Institutional investors own 24.22% of the company's stock.
Analyst Ratings Changes
A number of analysts have recently commented on the stock. Loop Capital reduced their price target on shares of Tempus AI from $57.00 to $52.00 and set a "buy" rating for the company in a research note on Tuesday, January 14th. Morgan Stanley boosted their target price on shares of Tempus AI from $50.00 to $60.00 and gave the company an "overweight" rating in a research note on Thursday, March 6th. Wolfe Research downgraded Tempus AI from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 26th. William Blair reiterated a "market perform" rating on shares of Tempus AI in a research report on Tuesday, February 25th. Finally, Guggenheim reissued a "buy" rating on shares of Tempus AI in a research report on Tuesday, February 25th. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to data from MarketBeat, Tempus AI has a consensus rating of "Moderate Buy" and an average target price of $61.18.
Check Out Our Latest Analysis on Tempus AI
Tempus AI Trading Down 9.1 %
NASDAQ:TEM traded down $5.32 during trading hours on Wednesday, hitting $53.25. 9,403,502 shares of the stock traded hands, compared to its average volume of 5,173,092. Tempus AI, Inc. has a 1 year low of $22.89 and a 1 year high of $91.45. The stock has a 50 day moving average price of $57.42 and a 200 day moving average price of $51.46. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55.
Insider Activity at Tempus AI
In related news, CEO Eric P. Lefkofsky sold 3,240,234 shares of the company's stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $58.75, for a total transaction of $190,363,747.50. Following the completion of the transaction, the chief executive officer now owns 4,895,589 shares in the company, valued at approximately $287,615,853.75. This represents a 39.83 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Jennifer A. Doudna sold 1,320 shares of Tempus AI stock in a transaction on Friday, February 14th. The shares were sold at an average price of $90.00, for a total transaction of $118,800.00. Following the completion of the sale, the director now owns 36,011 shares in the company, valued at approximately $3,240,990. This represents a 3.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 5,598,969 shares of company stock worth $317,194,162.
Tempus AI Profile
(
Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Read More
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
